281 related articles for article (PubMed ID: 27279237)
1. Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer.
Qin Y; Mohandessi S; Gordon L; Wadehra M
Crit Rev Oncog; 2015; 20(5-6):391-405. PubMed ID: 27279237
[TBL] [Abstract][Full Text] [Related]
2. Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web.
Morales SA; Telander D; Notterpek L; Wadehra M; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5465-72. PubMed ID: 21421883
[TBL] [Abstract][Full Text] [Related]
3. Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells.
Jung O; Choi S; Jang SB; Lee SA; Lim ST; Choi YJ; Kim HJ; Kim DH; Kwak TK; Kim H; Kang M; Lee MS; Park SY; Ryu J; Jeong D; Cheong HK; Kim HJ; Park KH; Lee BJ; Schlaepfer DD; Lee JW
J Cell Sci; 2012 Dec; 125(Pt 24):5960-73. PubMed ID: 23077174
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility.
Wang W; Liu Y; Liao K
BMC Cell Biol; 2011 Nov; 12():49. PubMed ID: 22078467
[TBL] [Abstract][Full Text] [Related]
5. FAK in cancer: mechanistic findings and clinical applications.
Sulzmaier FJ; Jean C; Schlaepfer DD
Nat Rev Cancer; 2014 Sep; 14(9):598-610. PubMed ID: 25098269
[TBL] [Abstract][Full Text] [Related]
6. Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling.
Berditchevski F; Odintsova E
J Cell Biol; 1999 Jul; 146(2):477-92. PubMed ID: 10427099
[TBL] [Abstract][Full Text] [Related]
7. FERM control of FAK function: implications for cancer therapy.
Lim ST; Mikolon D; Stupack DG; Schlaepfer DD
Cell Cycle; 2008 Aug; 7(15):2306-14. PubMed ID: 18677107
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).
Morales SA; Mareninov S; Coulam P; Wadehra M; Goodglick L; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4949-56. PubMed ID: 19494199
[TBL] [Abstract][Full Text] [Related]
9. FAK in Cancer: From Mechanisms to Therapeutic Strategies.
Chuang HH; Zhen YY; Tsai YC; Chuang CH; Hsiao M; Huang MS; Yang CJ
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163650
[TBL] [Abstract][Full Text] [Related]
10. Development of focal adhesion kinase inhibitors in cancer therapy.
Ma WW
Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
[TBL] [Abstract][Full Text] [Related]
11. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
Zhou J; Yi Q; Tang L
J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
[TBL] [Abstract][Full Text] [Related]
12. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
Schlaepfer DD; Jones KC; Hunter T
Mol Cell Biol; 1998 May; 18(5):2571-85. PubMed ID: 9566877
[TBL] [Abstract][Full Text] [Related]
13. Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine.
Chen F; Zhong Z; Zhang C; Lu Y; Chan YT; Wang N; Zhao D; Feng Y
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362132
[TBL] [Abstract][Full Text] [Related]
14. CD99 inhibits CD98-mediated β1 integrin signaling through SHP2-mediated FAK dephosphorylation.
Lee KJ; Yoo YH; Kim MS; Yadav BK; Kim Y; Lim D; Hwangbo C; Moon KW; Kim D; Jeoung D; Lee H; Lee JH; Hahn JH
Exp Cell Res; 2015 Aug; 336(2):211-22. PubMed ID: 26172215
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src.
Schlaepfer DD; Hunter T
J Biol Chem; 1997 May; 272(20):13189-95. PubMed ID: 9148935
[TBL] [Abstract][Full Text] [Related]
18. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
[TBL] [Abstract][Full Text] [Related]
19. Cell invasion by Neisseria meningitidis requires a functional interplay between the focal adhesion kinase, Src and cortactin.
Slanina H; Hebling S; Hauck CR; Schubert-Unkmeir A
PLoS One; 2012; 7(6):e39613. PubMed ID: 22768099
[TBL] [Abstract][Full Text] [Related]
20. Tspan8 and CD151 promote metastasis by distinct mechanisms.
Yue S; Mu W; Zöller M
Eur J Cancer; 2013 Sep; 49(13):2934-48. PubMed ID: 23683890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
